'Quiet!' Ukrainian soldiers fire on Russian positions near Bakhmut in terrifying POV footage

expand_more

1 views3 years ago

thumb_upLike

thumb_downDislike

library_addSave

flagReport

Daily Mail check_circle

1K subscribers

'Quiet!' Ukrainian soldiers fire on Russian positions near Bakhmut in terrifying POV footage. Soldiers of the 3rd Separate Assault Brigade, made up of the remnants of the Azov Battalion, were filmed fighting in a forested area near Bakhmut on May 25. Troops with heavy machine guns were filmed defending recently-captured Russian positions from an attack, then clearing out some more foxholes. #Ukraine #ukrainewar #ukrainerussia #russia #russiaukraine #russiaukrainewar #dailymail #bakhmut Daily Mail Homepage: https://www.dailymail.co.uk/ Daily Mail Facebook: https://facebook.com/dailymail Daily Mail IG: https://instagram.com/dailymail Daily Mail Snap: https://www.snapchat.com/discover/Daily-Mail/8392137033 Daily Mail Twitter: https://twitter.com/MailOnline Daily Mail Pinterest: https://pinterest.co.uk/dailymail Get the free Daily Mail mobile app: https://dailymail.co.uk/mobile

vid:152077

Comments0

unfold_more

00:00:24

Should Trump release the Epstein list?

more_vert

Daily Mail check_circle

10K views 1 year ago

00:00:15

Do you think Trump should release the Epstein list?

more_vert

Daily Mail check_circle

11K views 1 year ago

00:40:00

‘Prince Harry is trying to DIVIDE Prince William & the King!’ | Palace Confidential

more_vert

Daily Mail Royals check_circle

230K views 1 year ago

00:00:52

Exclusive Trump footage reveals makeup hiding bump on his hand

more_vert

Daily Mail check_circle

9K views 1 year ago

00:00:24

Trump on Epstein files: Republicans 'got duped'

more_vert

Daily Mail check_circle

11K views 1 year ago

keyboard_arrow_left

Tim Pool

Alex Jones Show

Bannons War Room

Trump

navigate_next

Kingdom Within check_circle

1 views 3 years ago

00:02:33

'Quiet!' Ukrainian soldiers fire on Russian positions near Bakhmut in terrifying POV footage

more_vert

Daily Mail check_circle

1 views 3 years ago

00:22:41

Antifa Attacks PARENTS Opposing Grooming In CA Schools, Dads Say ENOUGH To The Far Left CULT

more_vert

Timcast check_circle

1 views 3 years ago

00:11:26

HUGE: Biden Admin CANNOT Pressure Twitter, Facebook To CENSOR Speech, Judge RULES

more_vert

The Hill check_circle

1 views 3 years ago

,Briahna Joy Gray and Robby Soave discuss a rulling by federal judge to block communications between federal agencies and social media companies. #cisa #firstamendment According to the CDC, all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. Getting a COVID-19 vaccination is also a safer way to build protection than getting sick with COVID-19. COVID-19 vaccination helps protect you by creating an antibody response without you having to experience sickness. Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19. Getting sick with COVID-19 can cause severe illness or death, and we can’t reliably predict who will have mild or severe illness. If you get sick, you can spread COVID-19 to others. You can also continue to have long-term health issues after COVID-19 infection. According to the CDC all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Currently available data do not show ivermectin is effective against COVID-19. Clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing. Taking large doses of ivermectin is dangerous. If your health care provider writes you an ivermectin prescription, fill it through a legitimate source such as a pharmacy, and take it exactly as prescribed. Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dangerous. Source: https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 In April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines. These rare cases of myocarditis or pericarditis have occurred most frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna). There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson). CDC continues to recommend COVID-19 vaccination for everyone 6 months of age and older. The Advisory Committee on Immunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines. For more info: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/myocarditis.html According to the CDC, Atrazine is a widely used chlorotriazine herbicide active against broadleaf and grassy weeds. Related chlorotriazine herbicides include simazine, propazine, and cyanazine, all which act by inhibiting plant photosynthesis. Atrazine is applied pre- and post-emergence to agricultural land for crops such as corn and sorghum. It is also used as a non-selective herbicide. Atrazine was first registered as an herbicide in 1958. More than 70 million pounds have been applied annually in recent years, with about 75% of corn cropland receiving treatment. Atrazine has limited water solubility and is not tightly bound to soil, but is leachable in to ground and surface waters. In regions where atrazine is used, it is one of the more commonly detected pesticides in surface and ground waters (USGS, 2007). In soils, atrazine is slowly degraded to dealkylated products, which have half-lives of several months. Bacteria and plants can metabolize atrazine to hydroxyatrazine. Atrazine does not bioaccumulate. It has little toxicity in birds and moderate toxicity in some fish and aquatic invertebrates. Atrazine may alter the sexual development of frogs at environmental levels (Gammon et al., 2005; Hayes et al., 2002; U.S.EPA, 2003a).